v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT04757818 |
Full text link
Last imported at : Feb. 19, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : July 20, 2021, 4 p.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : July 20, 2021, 4 p.m. Source : ClinicalTrials.gov |
omitja@flsida.org |
Registration date
Last imported at : Feb. 19, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
2021-02-17 |
Recruitment status
Last imported at : July 20, 2021, 4 p.m. Source : ClinicalTrials.gov |
Completed |
Study design
Last imported at : Feb. 19, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Feb. 19, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Feb. 19, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : Feb. 19, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Blind label |
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
multi-center |
Study aim
Last imported at : Feb. 19, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Treatment |
Inclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
inclusion criteria: age equal to or greater than 18 years 2. confirmation of sars-cov-2 infection, determined by pcr or validated rapid antigen test1 from a nasopharyngeal smear performed in ≤3 days. without symptoms of covid-19 or with symptoms with ≤3 days of evolution cognitive and motor ability to perform mouthwashes and gargles willingness to comply with the requirements of the protocol understanding of the information provided in relation to the objectives and procedures provide your consent freely to participate in the study. |
Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
use of mouthwashes, in the last 24 hours use of vitis pastes and / or perio aid gel, in the last 24 hours four or more days of symptoms compatible with covid-19. recent medical diagnosis (≤ 1 month) of pneumonia cognitive impairment or other reason that, in the investigator's discretion, contraindicates participation in the study hyposialia |
Number of arms
Last imported at : Feb. 19, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : Feb. 19, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Dentaid SL |
Inclusion age min
Last imported at : Feb. 19, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : Feb. 19, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
100 |
Countries
Last imported at : Feb. 19, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Spain |
Type of patients
Last imported at : Feb. 19, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
Mild disease at enrollment |
Severity scale
Last imported at : Feb. 19, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
1: Mild disease at enrollment |
Total sample size
Last imported at : July 20, 2021, 4 p.m. Source : ClinicalTrials.gov |
118 |
primary outcome
Last imported at : July 20, 2021, 4 p.m. Source : ClinicalTrials.gov |
Nucleocapsid protein levels in saliva samples measured by ELISA;SARS-CoV-2 viral load in saliva samples measured by RT-qPCR |
Notes
Last imported at : Feb. 19, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
Not reported |
Arms
Last imported at : Feb. 19, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 268, "treatment_name": "Cetylpyridinium chloride", "treatment_type": "Mouthwash", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}] |